(Q39913160)

15 September 2017

title

Whole tumor cell vaccine with irradiated S180 cells as adjuvant (English)

1 reference

15 September 2017

Jinhua Li

1

1 reference

15 September 2017

Ada V King

2

1 reference

15 September 2017

Sara L Stickel

3

1 reference

15 September 2017

Kelly E Burgin

4

1 reference

15 September 2017

Xinhai Zhang

5

1 reference

15 September 2017

Thomas E Wagner

6

1 reference

15 September 2017

Yanzhang Wei

7

1 reference

15 September 2017

language of work or name

English

0 references

publication date

21 November 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

27

1 reference

15 September 2017

issue

4

1 reference

15 September 2017

page(s)

558-564

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

15 September 2017

1 reference

Clinical cancer vaccine trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

Cancer immunotherapy: novel strategies and clinical experiences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

Tumor-specific shared antigenic peptides recognized by human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

Immunotherapeutic potential of whole tumour cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

GM-CSF gene-modifed cancer cell immunotherapies: of mice and men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

Immunological gene therapy with ex vivo gene-modified tumor cells: a critique and a reappraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

Immunologic and genetic characterization of S180, a cell line of murine origin capable of growing in different inbred strains of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

Spontaneous regression of advanced cancer: Identification of a unique genetically determined, age-dependent trait in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

Transferable anticancer innate immunity in spontaneous regression/complete resistance mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

Non-small-cell lung cancer vaccine therapy: a concise review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

Autologous, hapten-modified vaccine as a treatment for human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.014

10.1016/J.VACCINE.2008.11.014

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference